Re-expression of HPV16 E2 in SiHa (human Cervical Cancer) Cells Potentiates NF-κB Activation Induced by TNF-α Concurrently Increasing Senescence and Survival
Overview
Affiliations
Re-expression of E2 in human papillomavirus (HPV) transformed tumour cells can induce apoptosis; however, some evidences also attribute an important role to E2 in sustaining tumorigenesis. In the present paper, we studied the effects of tumour necrosis factor (TNF)-α-mediated NF-κB (nuclear factor kappa-light-chain-enhancer of activated B-cells) activation on E2-induced senescence in HPV16-integrated SiHa cells. The results show that E2 inhibits endogenous E6 gene expression and sensitizes SiHa cells to TNF-α-induced NF-κB activation. Under this condition there was an increase in the expression of senescent proteins p53, p21, p27 and p16 and senescence-associated (SA)-β-galactosidase activity indicating that TNF-α augments E2-mediated senescence. Re-expression of E2 expression with TNF-α treatment resulted in an increase in the expression of anti-apoptotic Bcl2 (B-cell lymphoma 2) protein and other pro-survival genes like cyclin D1 (cyc D1), survivin and hTERT (human telomerase reverse transcriptase). Concomitantly, E2 + TNF-α combination increased the survival of SiHa cells by positive changes in viability, proliferation and colony formation. E2-induced apoptotic tendency shifted towards senescence in presence of TNF-α by arresting the cells at both G0/G1 and G2/M phases, thus enhancing cell survival. Another observation in the present study is the significant up-regulation of key senescence messaging factors regulated by NF-κB namely interleukin (IL)-6, IL-8, high-mobility group protein A (HMGA)1 and B (HMGB)1 in E2-transfected cells treated with TNF-α. Our data provide a mechanistic basis and a new insight for the role of TNF-α and E2 in linking cellular senescence, tumorigenesis and HPV re-infection.
Jamal D, Rozaimee Q, Osman N, Mohd Sukor A, Elias M, Shamaan N Int J Mol Sci. 2022; 23(20).
PMID: 36293403 PMC: 9604055. DOI: 10.3390/ijms232012554.
Therapeutic Effects of Natural Products on Cervical Cancer: Based on Inflammatory Pathways.
Zhou Z, Long H, Xu S, Li F, Cheng Y, Luo H Front Pharmacol. 2022; 13:899208.
PMID: 35645817 PMC: 9136176. DOI: 10.3389/fphar.2022.899208.
Advances in exosome biomarkers for cervical cancer.
Ran Z, Wu S, Ma Z, Chen X, Liu J, Yang J Cancer Med. 2022; 11(24):4966-4978.
PMID: 35578572 PMC: 9761094. DOI: 10.1002/cam4.4828.
Li M, Wu C, Muhammad J, Yan D, Tsuneyama K, Hatta H Redox Biol. 2020; 36:101632.
PMID: 32863233 PMC: 7358455. DOI: 10.1016/j.redox.2020.101632.
Ying Z, Wu Z, Li X, Dang H, Yin N, Gao C Int J Clin Exp Pathol. 2020; 10(9):9460-9467.
PMID: 31966819 PMC: 6965996.